CurifyLabs raises $14M to 3D-print personalised medicine

CurifyLabs raises $14M to 3D-print personalised medicine

Your prescription, printed to order. A Finnish startup wants to turn the back room of your pharmacy into a tiny, automated drug factory, and it just raised $14m to do it in America. CurifyLabs has closed a $14m (€12m) Series A, the company announced. The Helsinki firm makes machines and software that let pharmacies 3D-print […] This story continues at The Next Web

Finland’s CurifyLabs raises €12 million to expand 3D printing-based medicine compounding

CurifyLabs, a Helsinki-based HealthTech company transforming how personalised medicines are made, today announced the closing of a €12 million ($14 million) Series A round to expand U.S. operations, strengthen supply chain infrastructure, enhance customer support, and accelerate product innovation. The round was co-led by Sandwater and HealthCap, with participation from Tesi (Finnish Industry Investment Ltd.) and existing investors, including Li…

CurifyLabs’ second raise in 14 months: husband-and-wife startup lands $14M to automate personalised medicine

CurifyLabs has secured $14 million in Series A funding just 14 months after its last round. Sandwater and HealthCap co-led the round, with Tesi and Lifeline Ventures also participating. This Finnish healthtech company automates pharmacy compounding, a typically manual and error-prone process. Compounding creates custom-dosed medicines for children, cancer patients, and others who cannot use standard drugs. With this round, CurifyLabs’ total fund…